Tested Applications
| Positive WB detected in | mouse liver tissue, A431 cells, L02 cells, HEK-293 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
26321-1-AP targets C10orf46 in WB, IHC, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag23694 Product name: Recombinant human C10orf46 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-303 aa of BC038294 Sequence: MEESMEEEEGGSYEAMMDDQNHNNWEAAVDGFRQPLPPPPPPSSIPAPAREPPGGQLLAVPAVSVDRKGPKEGLPMGPQPPPEANGVIMMLKSCDAAAAVAKAAPAPTASSTININTSTSKFLMNVITIEDYKSTYWPKLDGAIDQLLTQSPGDYIPISYEQIYSCVYKCVCQQHSEQMYSDLIKKITNHLERVSKELQASPPDLYIERFNIALGQYMGALQSIVPLFIYMNKFYIETKLNRDLKDDLIKLFTEHVAEKHIYSLMPLLLEAQSTPFQVTPSTMANIVKGLYTLRPVSQNFTAV Predict reactive species |
| Full Name | chromosome 10 open reading frame 46 |
| Observed Molecular Weight | 41 kDa |
| GenBank Accession Number | BC038294 |
| Gene Symbol | C10orf46 |
| Gene ID (NCBI) | 143384 |
| RRID | AB_2880478 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q86Y37 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for C10orf46 antibody 26321-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The C10orf46 Polyclonal antibody (26321-1-AP) has a total of 2 citations:
- Molecular Therapy (2026) — AFP-specific T cell receptor study on pan-HLA-A(∗)02 recognition and tumor remission in mice.
- Frontiers in Immunology (2026) — CACUL1 in hepatocellular carcinoma progression, focusing on tumor cell proliferation and macrophage-mediated immune suppression.
The citations span research fields including immunology/tumor immunity (T cell receptors, cancer immunotherapy) and hepatocellular carcinoma oncology. Both publications are from 2026, reflecting recent immunology and liver cancer research.
| Species | Application | Title |
|---|---|---|
Mol Ther AFP-specific T cell receptors with fine-tuning affinity induce durable tumor remission in mice and acquire pan-HLA-A(∗)02 recognition. | ||
Front Immunol CACUL1 promotes hepatocellular carcinoma progression through enhanced tumor cell proliferation and macrophage-mediated immune suppression. |









